← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Institute Of Research And Development
Marseille
$11,487,437
Total funding
5
Grants
Funding over time
peak $2.1M · FY2007–22$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$11,487,437 · 5
By mechanism
U01$6,992,448 · 2
UM1$2,204,287 · 1
R01$2,183,868 · 1
R03$106,834 · 1
Investigators at Institute Of Research And Development
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$2,142,292
U01 · FY2008 · AI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$1,697,338
U01 · FY2007 · AI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$1,134,326
UM1 · FY2012 · AI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$1,035,825
U01 · FY2009 · AI
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$865,026
UM1 · FY2013 · AI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$479,336
U01 · FY2014 · HD
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$461,199
U01 · FY2012 · HD
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$457,666
U01 · FY2013 · HD
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$453,073
R01 · FY2018 · HD
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$445,447
R01 · FY2019 · HD
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$442,553
R01 · FY2020 · HD
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$433,628
R01 · FY2021 · HD
Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection$409,167
R01 · FY2022 · HD
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$294,395
U01 · FY2015 · HD
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$204,935
UM1 · FY2014 · AI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$188,154
U01 · FY2015 · HD
Program for HIV Prevention and Treatment-Clinical Trial Unit, Thailand$136,242
U01 · FY2010 · AI
Antiviral prophylaxis to prevent perinatal transmission of HBV in Thailand$100,000
U01 · FY2016 · HD
Kidney Tubular Dysfunction in Hepatitis B Mono-Infected Women Receiving a Short Tenofovir Disoproxil Fumarate Course in Pregnancy and Postpartum Period to Prevent Mother to Child Transmission$53,730
R03 · FY2018 · HD
Kidney Tubular Dysfunction in Hepatitis B Mono-Infected Women Receiving a Short Tenofovir Disoproxil Fumarate Course in Pregnancy and Postpartum Period to Prevent Mother to Child Transmission$53,104
R03 · FY2019 · HD